Mechanistic longacting Injectable Model for PLGA Polymer Implants
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=5N6_ryuSQwQ
Long-acting injectable (LAI) delivery methods have proven to be beneficial for a range of drug types and situations, including CNS drugs (patient adherence), hormone therapy for oncology, women and men health and HIV to name a few. Certara has developed a mechanistic PLGA polymer-based model for assessing drug distribution and performance of these formulations. In this webinar, the model for solid implant, in-situ gel implant, and microsphere depot implants was covered. These models have been used for regulatory submittal of novel drugs and complex generics. Case studies of tacrolimus and leuprolide were also shared • • Please visit us at https://www.certara.com/services/simc... to learn more.
#############################
